Evidence map›Paper›PMID 36969218›Full record

ArticleFrontiers in immunology2023

Association of

Aya Kawasaki, Ken-Ei Sada, Premita Ari Kusumawati, Fumio Hirano, Shigeto Kobayashi, Kenji Nagasaka, Takahiko Sugihara, Nobuyuki Ono, Takashi Fujimoto, Makio Kusaoi and 10 more

Open access · goldFull text read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. PeerJ · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Association ofFrontiers in immunology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 11 institutions in 1 country.

Aya KawasakiMolecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Ken-Ei SadaDepartment of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Premita Ari KusumawatiMolecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Fumio HiranoDepartment of Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
Shigeto KobayashiDepartment of Internal Medicine, Juntendo University Koshigaya Hospital, Saitama, Japan.
Kenji NagasakaDepartment of Rheumatology, Ome Municipal General Hospital, Ome, Japan.
Takahiko SugiharaDepartment of Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
Nobuyuki OnoDepartment of Rheumatology, Saga University, Saga, Japan.
Takashi FujimotoDepartment of General Medicine, Nara Medical University, Kashihara, Japan.
Makio KusaoiDepartment of Internal Medicine and Rheumatology, Juntendo University Faculty of Medicine, Tokyo, Japan.
Naoto TamuraDepartment of Internal Medicine and Rheumatology, Juntendo University Faculty of Medicine, Tokyo, Japan.
Yasuyoshi KusanagiDivision of Hematology and Rheumatology, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan.
Kenji ItohDivision of Hematology and Rheumatology, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan.
Takayuki SumidaDepartment of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Kunihiro YamagataDepartment of Nephrology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Hiroshi HashimotoJuntendo University School of Medicine, Tokyo, Japan.
Hirofumi MakinoOkayama University, Okayama, Japan.
Yoshihiro ArimuraDepartment of Nephrology and Rheumatology, Kyorin University School of Medicine, Mitaka, Japan.
Masayoshi HarigaiDivision of Rheumatology, Department of Internal Medicine, Tokyo Women's Medical University School of Medicine, Tokyo, Japan.
Naoyuki TsuchiyaMolecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
University of Tsukuba · JPJuntendo University · JPNational Defense Medical College · JPTokyo Medical and Dental University · JPAsahi Hospital · JPKōchi University · JPNara Medical University · JPOkayama University · JPOme Municipal General Hospital · JPSaga University · JPTokyo Women's Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Disease relapse remains a major problem in the management of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). In European populations, Methods: First, the association of Results: The association of Conclusion:

Indexed as

Anti-Neutrophil Cytoplasmic Antibody-Associated VasculitisMicroscopic PolyangiitisAntibodies, Antineutrophil CytoplasmicEast Asian PeopleHumansMyeloblastinPeroxidaseAntibodies, Antineutrophil CytoplasmicMyeloblastinPeroxidaseANCA-associated vasculitis (AAV)geneticsHLA-class IImicroscopic polyangiitis (MPA)MPO-ANCApolymorphismrelapse

Identifiers

PMID36969218
PMCPMC10030796
OpenAlexW4323567349

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read22
identifiers read4
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.